Keywords
HIV.
Immunosuppression
Mycoses
Opportunistic Infections
Public Health Surveillance
How to Cite
Abstract
Introduction: Mycosis is a health problem of great importance due to its frequency, clinical severity and resistance to azoles. Some studies have reported mycosis about 10% in person with Human Immunodeficiency Virus, with multiple etiologies such as Pneumocysti jirovecci, candidiasis, cryptococcosis, istoplasmosis and aspergillosis. Objective: To estimate the frequency and to characterize the fungal infections in patients of a specialized hospital for the care of people with HIV in Medellín-Colombia, 2013-2017. Methods: Descriptive observational cross-sectional study with 200 patients attended at the Hospital La María in Medellín. Secondary information source with sociodemographic and microbiological variables was used; analyzes included frequencies, confidence intervals for proportions and chi square test to compare the frequency of infection according to sex and age group, in SPSS 25.0. Results: The average age was 5.5 ± 17.3 and 66% were men. The overall frequency of fungal infections was 12.5% (CI 95% = 7.67-17.33), without statistical differences according to sex and age group. The prevalence of Candida spp. was 5.5% (CI 95% = 0.09-8.91), Histoplasma capsulatum and Cryptocuccus spp. 1.5% (CI 95% = 0.31-4.32) and spergillus fumigatus 0.5% (CI 95% = 0.01-2.75). Conclusion: We found a high frequency of fungal infections in the study population, with predominance of Candida albicans, this is a relevant finding to improve the surveillance of this type of infections in reference hospitals for the care of people with HIV/AIDS and establish baselines for further studies. MÉD.UIS. 2020;33(2):17-24
References
Instituto Nacional de Salud de Colombia. VIH/SIDA Colombia 2017. [Internet] 2018. Disponible en: https://www.ins.gov.co/ buscador-eventos/Informesdeevento/VIH- IDA%202017.pdf.
Secretaría Seccional de Salud y Protección Social de Antioquia. Eventos de interés en salud pública por subregiones y municipios. Antioquia 2007 – 2017. [Internet] 2018. Disponible en: https://www.dssa.gov.co/index.php?option=com_k2 amp;view=item&id=71:eventos-de-interes-en-saludpublica- por-subregiones-y-municipios-antioquia-2007- 2016&Itemid=119
González A, Tobón A. Infecciones micóticas oportunistas en pacientes con VIH/SIDA. Infectio. 2006; 10(4): 279-288.
Santamaría J, Sulibarria Z. Las micosis en los pacientes infectados por el VIH en la era de los tratamientos antirretrovirales de gran eficacia. Rev Iberoam Micol. 2002; 19: 5-8.
Meless D, Ba B, Faye M, Diby J, Nzoré S, Datté S, et al. Oral lesions among HIV-infected children on antiretroviral treatment in West Africa. Trop Med Int ealth.2014;19(3):246-55
Vidal J, Toniolo C, Paulino A, Colombo A, Dos Anjos Martins M, da Silva Meira C, et al. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil. Trop Med Int Health.2016;21(12):1539-1544.
Minta D, Sylla M, Traoré A, Soukho-Kaya A, Coulibaly I, Diallo K, et al. Malian first observation of disseminated African histoplasmosis with predominant bone ocalizations in an HIVnegative child in Bamako (Mali). Review of the literature. J Mycol Med. 2014; 24(2): 152-7.
Fortún J, Meije Y, Fresco G, Moreno S. Aspergilosis. Formas clínicas y tratamiento. Enferm infecc microbiol clín 2012; 30(4): 173-222.).
Castro-Jiménez M, Rey-Benito G, Duque-Beltrán S, Pinilla- Guevara C, Bello- Pieruccini S, Agudelo-Mahecha C, et al. Diagnóstico de micosis oportunistas en pacientes con VIH/sida: un estudio de casos en Colombia. Infectio. 2011; 15(2): 92-97.
Martins MD, Lozano-Chiu M, Rex JH. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associatted with trends toward reduced rates of arriage of fluconazol-resistant C. albicans in humman immunodeficiency virus- infected patients. Clin Infect Dis. 1998; 27(5): 1291-1294.
Valdez H, Gripshover BM, Salata RA, Lederman MM. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy. IDS 1998; 12(5): 538.
Zida A, Sawadogo PM, Diallo I, Tapsoba H, Bazie Z, Drabo YJ, et al. Epidemiological aspects of cutaneous mycosis of HIV-infected patients in the National Referral enter of Burkina Faso, West Africa. J Mycol Med. 2016; 26(2): 133-137.
Castillo N, Mouriño Rosa, Cornejo J, Gaitán L. Factores relacionados a candidiasis oral en niños y adolescentes con VIH, caracterización de especies y susceptibilidad ntifúngica. Rev chil infectol. 2018; 35(4): 377-385.
Rueda F, Hernández S, Gaitán L, Sánchez L, Lama E, Rodríguez M. Differences by resistotyping between C. albicans strains isolated from the oral cavity of HIV+ and seronegative patients. Odovtos. 2018; 20(2): 103-111.
Bruner K, Franco-Paredes C, Henao-Martínez AF, Steele GM, Chastain DB. Cryptococcus gattii complex infections in hivinfected patients, Southeastern United States. Emerg Infect Dis 2018; 24(11): 1998-2002.
Azambuja AZ, Wissmann Neto G, Watte G, Antoniolli L, Goldani LZ. Cryptococcal Meningitis: A Retrospective Cohort of a Brazilian Reference Hospital in the Post-HAART Era of UniversalAccess. Can J Infect Dis Med Microbiol. 2018; 2018(6): 1-5.
Nacher M, Blanchet D, Bongomin F, Chakrabarti A, Couppié P, Demar M, et al. Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: A systematic review of diagnostic accuracy studies. PLoS Negl Trop Dis. 2018; 12(10): e0006802.
Adenis AA, Valdes A, Cropet C, McCotter OZ, Derado G, Couppie P, et al. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018; 18(10): 1150-1159.
Kwizera R, Parkes-Ratanshi R, Page ID, Sekaggya-Wiltshire C, Musaazi J, Fehr J, et al. Elevated Aspergillus-specific antibody levels among HIV infected Ugandans ith pulmonary tuberculosis. BMC Pulm Med. 2017; 17(1): 149.
Kaur R, Mehra B, Dhakad MS, Goyal R, Bhalla P, Dewan R. Fungal Opportunistic Pneumonias in HIV/AIDS Patients: An Indian Tertiary Care Experience. J Clin Diagn Res. 2017; 11(2): DC14- DC19.
Canton E, García-Rodríguez J, Martín-Mazuelos E, Pemán J, Guinea J. Microbiological procedures for the diagnosis, management, and study of invasive fungal nfections. Enferm Infecc Microbiol Clin. 2014; 32(6): 375-9.
Caceres DH, Tobón AM, Restrepo A, Chiller T, Gómez BL. The important role of coinfections in patients with AIDS and progressive disseminated histoplasmosis (PDH): ohort from Colombia. Med Mycol Case Rep. 2018; 19: 41-44.
Caceres DH, Tobón AM, Cleveland AA, Scheel CM, Berbesi DY, Ochoa J, et al. Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency irus/AcquiredImmune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital. Am J Trop Med Hyg. 2016; 95(4): 918-924.
Agudelo C, Restrepo C, Molina DA, Tobón A, Kauffman C, Murillo C, et al. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg. 2012; 7(6): 1094-1098.
Tobón AM, Agudelo CA, Rosero DS, Ochoa JE, De Bedout C, Zuluaga A, et al. Disseminated histoplasmosis: a comparative study between patients with acquired mmunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg. 2005; 73(3): 576-582.
Escandón P, de Bedout C, Lizarazo J, Agudelo CI, Tobón A, Bello S, et al. Cryptococcosis in Colombia: results of the national surveillance program for the years 2006- 10. Biomedica. 2012; 32(3): 386-398.
Arango M, Castañeda E, Agudelo CI, De Bedout C, Agudelo CA, Tobón A, et al. Histoplasmosis: results of the Colombian national survey, 1992-2008. Biomedica. 2011; 1(3): 344-356.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Médicas UIS